These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32909960)

  • 1. Protection and regeneration of esophageal, pharyngeal, and laryngeal mucosa as a major element in therapy of patients with esophageal and extraesophageal reflux symptoms.
    Gąsiorowska A
    Otolaryngol Pol; 2020 Aug; 74(4):40-45. PubMed ID: 32909960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal impedance monitoring and pathophysiology of gastroesophageal reflux disease.
    Sifrim D
    Verh K Acad Geneeskd Belg; 2006; 68(3):151-78. PubMed ID: 16796016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection].
    Maev IV; Andreev DN; Kucheryavyy YA; Shaburov RI
    Ter Arkh; 2019 Aug; 91(8):4-11. PubMed ID: 32598747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of gastro-esophageal reflux disease: a role for mucosa integrity?
    Farré R
    Neurogastroenterol Motil; 2013 Oct; 25(10):783-99. PubMed ID: 23937353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
    Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T
    J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis of gastro-esophageal reflux disease].
    Oshima T; Miwa H
    Nihon Rinsho; 2007 May; 65(5):797-801. PubMed ID: 17511216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extraesophageal signs of gastroesophageal reflux disease: otorhinolaryngologist's view].
    Radtsig EY; Konstantinov DI
    Ter Arkh; 2021 Apr; 93(4):521-525. PubMed ID: 36286791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.
    Kandulski A; Malfertheiner P
    Nat Rev Gastroenterol Hepatol; 2011 Nov; 9(1):15-22. PubMed ID: 22105108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise role of acid in non-erosive reflux disease.
    Wang C; Hunt RH
    Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of the esophageal pre-epithelial barrier components in the maintenance of integrity of the esophageal mucosa in patients with endoscopically negative gastroesophageal reflux disease.
    Marcinkiewicz M; Han K; Zbroch T; Poplawski C; Gramley W; Goldin G; Sarosiek J
    Am J Gastroenterol; 2000 Jul; 95(7):1652-60. PubMed ID: 10925964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of pathophysiological features of GERD.
    Usai Satta P; Oppia F; Cabras F
    Minerva Gastroenterol Dietol; 2017 Sep; 63(3):184-197. PubMed ID: 28251844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease.
    Postma GN; Tomek MS; Belafsky PC; Koufman JA
    Ann Otol Rhinol Laryngol; 2001 Dec; 110(12):1114-6. PubMed ID: 11768699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
    Mine S; Iida T; Tabata T; Okada Y; Tanaka Y
    J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease.
    Tack J
    Curr Opin Gastroenterol; 2005 Jul; 21(4):454-60. PubMed ID: 15930988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic and physiologic outcomes after operative treatment for extraesophageal reflux.
    Oelschlager BK; Eubanks TR; Oleynikov D; Pope C; Pellegrini CA
    Surg Endosc; 2002 Jul; 16(7):1032-6. PubMed ID: 11984664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ethiopathogenesis of gastroesophageal reflux disease].
    Lukás K; Marecek P
    Cas Lek Cesk; 2000 Aug; 139(15):455-9. PubMed ID: 22666924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease.
    Rohof WO; Bennink RJ; de Jonge H; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1647-55. PubMed ID: 24184737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
    Triadafilopoulos G; Kaczynska M; Iwane M
    Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal mucosal sensitivity: possible links with clinical presentations in patients with erosive esophagitis and laryngopharyngeal reflux.
    Korkmaz M; Tarhan E; Unal H; Selcuk H; Yilmaz U; Ozluoglu L
    Dig Dis Sci; 2007 Feb; 52(2):451-6. PubMed ID: 17219066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal dysmotility and gastroesophageal reflux disease.
    Diener U; Patti MG; Molena D; Fisichella PM; Way LW
    J Gastrointest Surg; 2001; 5(3):260-5. PubMed ID: 11360049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.